Found: 59
Select item for more details and to access through your institution.
Efficacy of anti-epidermal growth factor antibody rechallenge in RAS/BRAF wild-type metastatic colorectal cancer: a multi-institutional observational study.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2024, v. 150, n. 7, p. 1, doi. 10.1007/s00432-024-05893-1
- By:
- Publication type:
- Article
KRAS mutation as a predictor of insufficient trastuzumab efficacy and poor prognosis in HER2-positive advanced gastric cancer.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 3, p. 1273, doi. 10.1007/s00432-022-03966-7
- By:
- Publication type:
- Article
Severe ischemic colitis after treatment of bile-duct cancer using gemcitabine and cisplatin.
- Published in:
- Japanese Journal of Clinical Oncology, 2015, v. 45, n. 4, p. 402, doi. 10.1093/jjco/hyv038
- By:
- Publication type:
- Article
Potent molecular-targeted therapies for gastro-entero-pancreatic neuroendocrine carcinoma.
- Published in:
- Cancer & Metastasis Reviews, 2023, v. 42, n. 3, p. 1021, doi. 10.1007/s10555-023-10121-2
- By:
- Publication type:
- Article
Advantages of magnifying narrow-band imaging for diagnosing colorectal cancer coexisting with sessile serrated adenoma/polyp.
- Published in:
- Digestive Endoscopy, 2016, v. 28, p. 53, doi. 10.1111/den.12631
- By:
- Publication type:
- Article
Potent molecular-targeted therapies for advanced esophageal squamous cell carcinoma.
- Published in:
- Therapeutic Advances in Medical Oncology, 2023, p. 1, doi. 10.1177/17588359221138377
- By:
- Publication type:
- Article
ASO Author Reflections: The Role of CEA Optimizing Perioperative Treatments for Colorectal Cancer with Liver Metastases.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2022, v. 29, n. 13, p. 8394, doi. 10.1245/s10434-022-12372-9
- By:
- Publication type:
- Article
ASO Visual Abstract: Clinical Usefulness of Postoperative Serum Carcinoembryonic Antigen in Patients with Colorectal Cancer with Liver Metastases.
- Published in:
- 2022
- By:
- Publication type:
- Abstract
Clinical Usefulness of Postoperative Serum Carcinoembryonic Antigen in Patients with Colorectal Cancer with Liver Metastases.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2022, v. 29, n. 13, p. 8385, doi. 10.1245/s10434-022-12301-w
- By:
- Publication type:
- Article
Neoadjuvant Chemoradiotherapy with Cisplatin Plus Fluorouracil for Borderline Resectable Esophageal Squamous Cell Carcinoma.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2020, v. 27, n. 5, p. 1510, doi. 10.1245/s10434-019-08124-x
- By:
- Publication type:
- Article
Clinical utility of polyethylene glycol conjugated granulocyte colony-stimulating factor (PEG-G-CSF) for preventing severe neutropenia in metastatic colorectal cancer patients treated with FOLFOXIRI plus bevacizumab: a single-center retrospective study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
A phase I study to determine the maximum tolerated dose of trifluridine/tipiracil and oxaliplatin in patients with refractory metastatic colorectal cancer: LUPIN study.
- Published in:
- Investigational New Drugs, 2020, v. 38, n. 1, p. 111, doi. 10.1007/s10637-019-00749-9
- By:
- Publication type:
- Article
Clinical outcomes and prognostic factors of concurrent chemoradiotherapy for anal squamous cell carcinoma in Japan.
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 8, p. 1161, doi. 10.1007/s10147-024-02540-0
- By:
- Publication type:
- Article
Exploratory analysis of serum HER2 extracellular domain for HER2 positive gastric cancer treated with SOX plus trastuzumab.
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 6, p. 801, doi. 10.1007/s10147-024-02509-z
- By:
- Publication type:
- Article
Morphological response and tumor shrinkage as predictive factors in metastatic colorectal cancer treated with first-line capecitabine, oxaliplatin, and bevacizumab.
- Published in:
- International Journal of Clinical Oncology, 2023, v. 28, n. 9, p. 1191, doi. 10.1007/s10147-023-02370-6
- By:
- Publication type:
- Article
Treatment efficacy of ramucirumab-containing chemotherapy in patients with alpha-fetoprotein producing gastric cancer.
- Published in:
- International Journal of Clinical Oncology, 2023, v. 28, n. 1, p. 121, doi. 10.1007/s10147-022-02263-0
- By:
- Publication type:
- Article
Managing a gastrointestinal oncology practice in Japan during the COVID-19 pandemic: single institutional experience in The Cancer Institute Hospital of Japanese Foundation for Cancer Research.
- Published in:
- International Journal of Clinical Oncology, 2021, v. 26, n. 2, p. 335, doi. 10.1007/s10147-020-01806-7
- By:
- Publication type:
- Article
A retrospective analysis of ramucirumab monotherapy in previously treated Japanese patients with advanced or metastatic gastric adenocarcinoma.
- Published in:
- International Journal of Clinical Oncology, 2018, v. 23, n. 1, p. 92, doi. 10.1007/s10147-017-1192-0
- By:
- Publication type:
- Article
Retrospective comparison of S-1 plus cisplatin versus S-1 monotherapy for the treatment of advanced gastric cancer patients with positive peritoneal cytology but without gross peritoneal metastasis.
- Published in:
- International Journal of Clinical Oncology, 2017, v. 22, n. 6, p. 1060, doi. 10.1007/s10147-017-1164-4
- By:
- Publication type:
- Article
Circulating Tumor DNA: The Dawn of a New Era in the Optimization of Chemotherapeutic Strategies for Metastatic Colo-Rectal Cancer Focusing on RAS Mutation.
- Published in:
- Cancers, 2023, v. 15, n. 5, p. 1473, doi. 10.3390/cancers15051473
- By:
- Publication type:
- Article
Circulating Tumor DNA as a Novel Biomarker Optimizing Chemotherapy for Colorectal Cancer.
- Published in:
- Cancers, 2020, v. 12, n. 6, p. 1566, doi. 10.3390/cancers12061566
- By:
- Publication type:
- Article
Single-organ pulmonary metastasis is a favorable prognostic factor in metastatic colorectal cancer patients treated with FOLFIRI and vascular endothelial growth factor inhibitors.
- Published in:
- BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-11067-y
- By:
- Publication type:
- Article
Clinical utility of the carcinoembryonic antigen level in patients with stage III colon cancer after surgery and adjuvant chemotherapy.
- Published in:
- Surgery Today, 2024, v. 54, n. 7, p. 692, doi. 10.1007/s00595-023-02779-6
- By:
- Publication type:
- Article
Clinical outcomes of radical gastrectomy following trastuzumab-based chemotherapy for stage IV HER2-positive gastric or gastroesophageal junction cancer.
- Published in:
- Surgery Today, 2020, v. 50, n. 10, p. 1240, doi. 10.1007/s00595-020-02011-9
- By:
- Publication type:
- Article
Correlation between circulating tumor DNA and carcinoembryonic antigen levels in patients with metastatic colorectal cancer.
- Published in:
- Cancer Medicine, 2021, v. 10, n. 24, p. 8820, doi. 10.1002/cam4.4384
- By:
- Publication type:
- Article
Early hypertension and neutropenia are predictors of treatment efficacy in metastatic colorectal cancer patients administered FOLFIRI and vascular endothelial growth factor inhibitors as second‐line chemotherapy.
- Published in:
- Cancer Medicine, 2021, v. 10, n. 2, p. 615, doi. 10.1002/cam4.3638
- By:
- Publication type:
- Article
Clinical relevance of circulating tumor DNA assessed through deep sequencing in patients with metastatic colorectal cancer.
- Published in:
- Cancer Medicine, 2019, v. 8, n. 1, p. 408, doi. 10.1002/cam4.1913
- By:
- Publication type:
- Article
Early change in circulating tumor DNA as a potential predictor of response to chemotherapy in patients with metastatic colorectal cancer.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-53711-3
- By:
- Publication type:
- Article
Acquired drug resistance conferred by a KRAS gene mutation following the administration of cetuximab: a case report.
- Published in:
- 2013
- By:
- Publication type:
- Case Study
Angiotensin II type-1 receptor blockers enhance the effects of bevacizumab-based chemotherapy in metastatic colorectal cancer patients.
- Published in:
- Molecular & Clinical Oncology, 2015, v. 3, n. 6, p. 1295, doi. 10.3892/mco.2015.630
- By:
- Publication type:
- Article
Cetuximab treatment for metastatic colorectal cancer with KRAS p.G13D mutations improves progression-free survival.
- Published in:
- Molecular & Clinical Oncology, 2015, v. 3, n. 5, p. 1053, doi. 10.3892/mco.2015.602
- By:
- Publication type:
- Article
Efficacy and Safety of Trastuzumab Deruxtecan and Nivolumab as Third- or Later-Line Treatment for HER2-Positive Advanced Gastric Cancer: A SingleInstitution Retrospective Study.
- Published in:
- Journal of Gastric Cancer, 2023, v. 23, n. 4, p. 609, doi. 10.5230/jgc.2023.23.e41
- By:
- Publication type:
- Article
Changes in the neutrophil-to-lymphocyte ratio during nivolumab monotherapy are associated with gastric cancer survival.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Second-line FOLFIRI plus ramucirumab with or without prior bevacizumab for patients with metastatic colorectal cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Clinical impact of Epstein‐Barr virus status on the incidence of lymph node metastasis in early gastric cancer.
- Published in:
- Digestive Endoscopy, 2020, v. 32, n. 3, p. 316, doi. 10.1111/den.13584
- By:
- Publication type:
- Article
Evaluation of the RAS signaling network in response to MEK inhibition using organoids derived from a familial adenomatous polyposis patient.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41598-020-74530-x
- By:
- Publication type:
- Article
Non‐V600E BRAF mutations and EGFR signaling pathway in colorectal cancer.
- Published in:
- International Journal of Cancer, 2019, v. 145, n. 9, p. 2488, doi. 10.1002/ijc.32320
- By:
- Publication type:
- Article
RAS mutation is a prognostic biomarker in colorectal cancer patients with metastasectomy.
- Published in:
- International Journal of Cancer, 2016, v. 139, n. 4, p. 803, doi. 10.1002/ijc.30106
- By:
- Publication type:
- Article
Potent therapeutic strategy in gastric cancer with microsatellite instability-high and/or deficient mismatch repair.
- Published in:
- Gastric Cancer, 2024, v. 27, n. 5, p. 907, doi. 10.1007/s10120-024-01523-4
- By:
- Publication type:
- Article
Risk stratification for lymph node metastasis using Epstein–Barr virus status in submucosal invasive (pT1) gastric cancer without lymphovascular invasion: a multicenter observational study.
- Published in:
- Gastric Cancer, 2019, v. 22, n. 6, p. 1176, doi. 10.1007/s10120-019-00963-7
- By:
- Publication type:
- Article
Correction to: Clinical significance of intratumoral HER2 heterogeneity on trastuzumab efficacy using endoscopic biopsy specimens in patients with advanced HER2 positive gastric cancer.
- Published in:
- 2019
- By:
- Publication type:
- Correction Notice
Clinical significance of intratumoral HER2 heterogeneity on trastuzumab efficacy using endoscopic biopsy specimens in patients with advanced HER2 positive gastric cancer.
- Published in:
- Gastric Cancer, 2019, v. 22, n. 3, p. 518, doi. 10.1007/s10120-018-0887-x
- By:
- Publication type:
- Article
Associations between early tumor shrinkage and depth of response and clinical outcomes in patients treated with 1st-line chemotherapy for advanced gastric cancer.
- Published in:
- Gastric Cancer, 2018, v. 21, n. 2, p. 267, doi. 10.1007/s10120-017-0729-2
- By:
- Publication type:
- Article
Clinicopathological features of Siewert type II adenocarcinoma: comparison of gastric cardia adenocarcinoma and Barrett's esophageal adenocarcinoma following endoscopic submucosal dissection.
- Published in:
- Gastric Cancer, 2017, v. 20, n. 4, p. 663, doi. 10.1007/s10120-016-0653-x
- By:
- Publication type:
- Article
Chemotherapy is effective for stage I gastric cancer in patients with synchronous esophageal cancer.
- Published in:
- Gastric Cancer, 2016, v. 19, n. 2, p. 625, doi. 10.1007/s10120-015-0517-9
- By:
- Publication type:
- Article
Epstein-Barr virus status is a promising biomarker for endoscopic resection in early gastric cancer: proposal of a novel therapeutic strategy.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Clinical impact of intratumoral HER2 heterogeneity on trastuzumab efficacy in patients with HER2-positive gastric cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Safety and efficacy of amrubicin monotherapy in patients with platinum-refractory metastatic neuroendocrine carcinoma of the gastrointestinal tract: a single cancer center retrospective study.
- Published in:
- Cancer Management & Research, 2019, v. 11, p. 5757, doi. 10.2147/CMAR.S201048
- By:
- Publication type:
- Article
Treatment features of systemic chemotherapy in young adults with unresectable advanced or recurrent gastric cancer.
- Published in:
- Cancer Management & Research, 2018, v. 10, p. 5283, doi. 10.2147/CMAR.S179219
- By:
- Publication type:
- Article
Clinical Progress in Inoperable or Recurrent Advanced Gastric Cancer Treatment from 1004 Single Institute Experiences Between 2007 and 2018.
- Published in:
- Oncologist, 2022, v. 27, n. 6, p. e506, doi. 10.1093/oncolo/oyab069
- By:
- Publication type:
- Article